Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: profile report.

× No keyword cloud information.

13 in total

Review 1. Vascular adrenoceptors: an update.

Authors: S Guimarães; D Moura
Journal: Pharmacol Rev Date: 2001-06 Impact factor: 25.468

2. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal: Am J Obstet Gynecol Date: 2002-07 Impact factor: 8.661

Review 3. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.

Authors: J Sausville; M Naslund
Journal: Int J Clin Pract Date: 2010-12 Impact factor: 2.503

4. Side Effects of alpha-Blocker Use: Retrograde Ejaculation.

Authors: Steven A Kaplan
Journal: Rev Urol Date: 2009

Review 5. Silodosin: treatment of the signs and symptoms of benign prostatic hyperplasia.

Authors: Monique P Curran
Journal: Drugs Date: 2011-05-07 Impact factor: 9.546

Review 6. Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.

Authors: Herbert Lepor; Lawrence A Hill
Journal: Pharmacotherapy Date: 2010-12 Impact factor: 4.705

7. Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature.

Authors: S Murata; T Taniguchi; M Takahashi; K Okada; K Akiyama; I Muramatsu
Journal: J Urol Date: 2000-08 Impact factor: 7.450

8. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.

Authors: Leonard S Marks; Marc C Gittelman; Lawrence A Hill; Weining Volinn; Gary Hoel
Journal: J Urol Date: 2009-04-16 Impact factor: 7.450

9. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.

Authors: K Shibata; R Foglar; K Horie; K Obika; A Sakamoto; S Ogawa; G Tsujimoto
Journal: Mol Pharmacol Date: 1995-08 Impact factor: 4.436

Review 10. Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.

Authors: Masaki Yoshida; Yukio Homma; Kazuki Kawabe
Journal: Expert Opin Investig Drugs Date: 2007-12 Impact factor: 6.206